TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8027961

Group type: EXPERIMENTAL
Intervention: Laboratory reactivity tasks (isometric handgrip, mental arithmetic, structured discussion)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Discussion task
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Overall lab mean for SBP
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Math task
Number of subjects: 126
Study: 2512936

Group type: EXPERIMENTAL
Intervention: Inpatient therapy
Number of subjects: 71

Group type: COMPARATOR
Intervention: Intensive outpatient therapy
Number of subjects: 71
Study: 897965

Group type: EXPERIMENTAL
Intervention: MTX plus BCG
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MTX plus BCG plus INH
Number of subjects: 0

Group type: COMPARATOR
Intervention: MTX alone
Number of subjects: 0
Study: 31309699

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg once daily
Number of subjects: 4744

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 4744
Study: 29512795

Group type: EXPERIMENTAL
Intervention: Inhaled nitrous oxide (MEOPA)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study: 25494860

Group type: EXPERIMENTAL
Intervention: Caloric restriction diet alone
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Caloric restriction diet + resistance training
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (caloric restriction diet alone)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 93
Study: 22441111

Group type: EXPERIMENTAL
Intervention: Probiotics supplementation
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 21489738

Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI)
Number of subjects: 511

Group type: COMPARATOR
Intervention: Control
Number of subjects: 511
Study: 19298339

Group type: EXPERIMENTAL
Intervention: Lactoferrin supplementation
Number of subjects: 1343

Group type: COMPARATOR
Intervention: No lactoferrin supplementation (Control)
Number of subjects: 1343
Study: 17630678

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting with distal emboli protection using the PRECISE Nitinol Stent and the ANGIOGUARD XP Emboli Capture Guidewire
Number of subjects: 1158

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting with distal emboli protection
Number of subjects: 1158
Study: 15111138

Group type: EXPERIMENTAL
Intervention: High frequency exercise program (twice daily, including weekends)
Number of subjects: 246

Group type: COMPARATOR
Intervention: Low frequency exercise program (once daily, not on weekends)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: High frequency exercise program
Number of subjects: 246

Group type: COMPARATOR
Intervention: Low frequency exercise program
Number of subjects: 246
Study: 11676354

Group type: EXPERIMENTAL
Intervention: Epoetin beta 5000 IU
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Epoetin beta 1000 IU
Number of subjects: 180

Group type: COMPARATOR
Intervention: Best supportive care and blood transfusions (if clinically indicated)
Number of subjects: 180
Study: 9054253

Group type: EXPERIMENTAL
Intervention: High-dose mivazerol (1.5 micrograms.kg‐1.h‐1)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Low-dose mivazerol (0.75 microgram.kg‐1.h‐1)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 7523907

Group type: EXPERIMENTAL
Intervention: TGr mutant T-lymphocytes
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Calculated mutation frequency
Number of subjects: 58
Study: 3662745

Group type: EXPERIMENTAL
Intervention: Yohimbine (20 mg)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 28770099

Group type: EXPERIMENTAL
Intervention: BRiMS programme plus usual care
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 60
Study: 27420150

Group type: EXPERIMENTAL
Intervention: Falls Management Exercise (FaME)
Number of subjects: 1256

Group type: EXPERIMENTAL
Intervention: Otago Exercise Programme (OEP)
Number of subjects: 1256

Group type: EXPERIMENTAL
Intervention: Falls Management Exercise (FaME) and Otago Exercise Programme (OEP)
Number of subjects: 1256
Study: 26385666

Group type: EXPERIMENTAL
Intervention: Standard fluid therapy with supplementary intraoperative stroke volume optimization (mean 956 ml Gelofusine)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Standard fluid therapy (control group)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Standard fluid therapy with supplementary intraoperative stroke volume optimization
Number of subjects: 220
Study: 24009303

Group type: EXPERIMENTAL
Intervention: High-fat diet (40% of caloric intake; n = 370)
Number of subjects: 738

Group type: COMPARATOR
Intervention: Low-fat diet (20% caloric intake; n = 368)
Number of subjects: 738

Group type: EXPERIMENTAL
Intervention: High-fat diet
Number of subjects: 738

Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 738

Group type: EXPERIMENTAL
Intervention: rs2943641 variant
Number of subjects: 738
Study: 21904231

Group type: EXPERIMENTAL
Intervention: 65% 1RM
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: 90% 1RM
Number of subjects: 147
Study: 18054930

Group type: EXPERIMENTAL
Intervention: Transdermal estrogen supplementation (100 microg/d)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No transdermal estrogen supplementation
Number of subjects: 100
Study: 16793154

Group type: EXPERIMENTAL
Intervention: Single-fraction radiotherapy (8 Gy x 1)
Number of subjects: 376

Group type: COMPARATOR
Intervention: Multiple-fraction radiotherapy (3 Gy x 10)
Number of subjects: 376
Study: 14575384

Group type: EXPERIMENTAL
Intervention: Taxan combined with carboplatin
Number of subjects: 25
Study: 10913925

Group type: EXPERIMENTAL
Intervention: Clodronate taken 2 hours before breakfast
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Clodronate taken 1 hour before breakfast
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Clodronate taken 0.5 hours before breakfast
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Clodronate taken 2 hours after breakfast
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Clodronate taken with breakfast
Number of subjects: 31
Study: 8818502

Group type: EXPERIMENTAL
Intervention: Fast neutron therapy
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Surgical treatment for primary site recurrence
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Fistula repair
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Surgical treatment of locoregional recurrence
Number of subjects: 28
Study: 1431012

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Mianserin
Number of subjects: 60
Study: 3888810

Group type: COMPARATOR
Intervention: Ampicillin-tobramycin
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Cefotaxime
Number of subjects: 73
Study: 31574261

Group type: EXPERIMENTAL
Intervention: 0.1-mL lavender oil diffusion
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 0.3-mL lavender oil diffusion
Number of subjects: 90

Group type: COMPARATOR
Intervention: No oil (control group)
Number of subjects: 90
Study: 29424786

Group type: EXPERIMENTAL
Intervention: Immediate ART
Number of subjects: 592

Group type: COMPARATOR
Intervention: Deferred ART
Number of subjects: 592
Study: 26779620

Group type: EXPERIMENTAL
Intervention: Spirulina maxima supplementation (2 g daily for 3 months)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (2 g daily for 3 months)
Number of subjects: 50
Study: 25259745

Group type: EXPERIMENTAL
Intervention: aTRH
Number of subjects: 14864
Study: 22648340

Group type: EXPERIMENTAL
Intervention: Exercise at three intensities
Number of subjects: 6

Group type: COMPARATOR
Intervention: Breathing room air at rest
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Breathing 100% oxygen during mild exercise at 63 ± 15 W
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Moderate exercise under room air conditions
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Combination of mild exercise, hyperventilation, and normobaric hyperoxia (100% oxygen inhalation)
Number of subjects: 6
Study: 20117456

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) with stenting
Number of subjects: 510

Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: PCI with stenting
Number of subjects: 510

Group type: COMPARATOR
Intervention: CABG
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (subset of PCI patients)
Number of subjects: 510
Study: 18003938

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo (no CEL subgroup)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo (low CEL subgroup)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo (high CEL subgroup)
Number of subjects: 65
Study: 16631880

Group type: EXPERIMENTAL
Intervention: bivalent HPV‐16/18 virus‐like particle AS04 vaccine
Number of subjects: 776

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 776
Study: 14725411

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (10 mg elemental zinc as zinc sulphate)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (no zinc supplementation)
Number of subjects: 300
Study: 11083892

Group type: EXPERIMENTAL
Intervention: Beta agonist treatment
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Hormone treatment
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conservative treatment for pneumothorax
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Surgical treatment for chylous effusions
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Screening for renal angiomyolipoma by CT scanning
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Pregnancy after diagnosis
Number of subjects: 50
Study: 8823238

Group type: EXPERIMENTAL
Intervention: Sumatriptan plus nitroglycerin
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo plus nitroglycerin
Number of subjects: 10
Study: 1728708

Group type: EXPERIMENTAL
Intervention: Diclofenac, 75 mg intramuscularly twice daily
Number of subjects: 44
Study: 6428590

Group type: EXPERIMENTAL
Intervention: Budesonide (non‐halogenated glucocorticoid) administered by nasal inhaler
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 0
Study: 30530637

Group type: EXPERIMENTAL
Intervention: Digital video intervention watched by parents in intervention clinics
Number of subjects: 1596

Group type: COMPARATOR
Intervention: Control clinic (no intervention)
Number of subjects: 1596

Group type: EXPERIMENTAL
Intervention: Parents watched the video
Number of subjects: 1596
Study: 27476829

Group type: EXPERIMENTAL
Intervention: CAD/CAM customized zirconia abutment
Number of subjects: 50

Group type: COMPARATOR
Intervention: Stock zirconia abutment
Number of subjects: 50
Study: 25950595

Group type: EXPERIMENTAL
Intervention: Buprenorphine treatment
Number of subjects: 300
Study: 24738837

Group type: EXPERIMENTAL
Intervention: Self-weighing combined with a self-management intervention
Number of subjects: 0
Study: 22624531

Group type: EXPERIMENTAL
Intervention: 6% hydroxyethylstarch 130/0.4 (HES)
Number of subjects: 196

Group type: COMPARATOR
Intervention: 0.9% NaCl (NaCl)
Number of subjects: 196
Study: 19757261

Group type: EXPERIMENTAL
Intervention: PregVit (n = 106)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Orifer F (n = 96)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: PregVit and Orifer F
Number of subjects: 202
Study: 17267099

Group type: EXPERIMENTAL
Intervention: Photodynamic diagnostic (PDD)
Number of subjects: 301

Group type: COMPARATOR
Intervention: White light (WL) cystoscopy
Number of subjects: 301
Study: 15106023

Group type: EXPERIMENTAL
Intervention: Occipitomental radiographs from general practice
Number of subjects: 247

Group type: COMPARATOR
Intervention: Occipitomental radiographs from a certified laboratory
Number of subjects: 247
Study: 11499848

Group type: EXPERIMENTAL
Intervention: Diclofenac prescriptions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple propensity score adjustment
Number of subjects: 0
Study: 9272412

Group type: EXPERIMENTAL
Intervention: 200 mg itraconazole for 4 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo for 4 days
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 200 mg itraconazole
Number of subjects: 10
Study: 7878629

Group type: EXPERIMENTAL
Intervention: 2 mg recombinant tissue plasminogen activator (t‐PA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 10,000 units of urokinase (UK)
Number of subjects: 50
Study: 3071175

Group type: EXPERIMENTAL
Intervention: Preoperative continuous nifedipine maintenance medication (10-20 mg p.o.)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Nifedipine morning dose
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (last nifedipine medication evening before surgery)
Number of subjects: 21
Study: 29632081

Group type: EXPERIMENTAL
Intervention: REACH‐HF intervention plus usual care
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: REACH‐HF intervention
Number of subjects: 50
Study: 28414485

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure therapy with incentives (PE + I; max $480)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Prolonged Exposure therapy (PE)
Number of subjects: 58
Study: 25682177

Group type: EXPERIMENTAL
Intervention: Nuclear cataract increase of 1.0 unit or more compared with less than 1.0‐unit change at 2 years
Number of subjects: 3466

Group type: EXPERIMENTAL
Intervention: Cortical cataract increase of 5% or more in lens opacity in the central 5 mm of the lens compared with less than 5% increase at 2 years
Number of subjects: 3466

Group type: EXPERIMENTAL
Intervention: Posterior subcapsular cataract increase of 5% or more versus less than 5% in the central 5 mm of the lens
Number of subjects: 3466

Group type: EXPERIMENTAL
Intervention: Nuclear cataract changes at 2 years
Number of subjects: 3466

Group type: EXPERIMENTAL
Intervention: Cortical cataract changes at 2 years
Number of subjects: 3466

Group type: EXPERIMENTAL
Intervention: Posterior subcapsular cataract changes at 2 years
Number of subjects: 3466
Study: 23046014

Group type: EXPERIMENTAL
Intervention: Methyl aminolevulinate (MAL) PDT with red light (22 J/cm²)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Methyl aminolevulinate (MAL) PDT with intense pulsed light (IPL) (8-10 J/cm²)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Methyl aminolevulinate (MAL) PDT with red light
Number of subjects: 20

Group type: COMPARATOR
Intervention: Methyl aminolevulinate (MAL) PDT with IPL
Number of subjects: 20
Study: 20628391

Group type: EXPERIMENTAL
Intervention: irinotecan/5FU
Number of subjects: 149
Study: 19064592

Group type: EXPERIMENTAL
Intervention: iomeprol-400
Number of subjects: 183

Group type: COMPARATOR
Intervention: iodixanol-320
Number of subjects: 183
Study: 16869923

Group type: EXPERIMENTAL
Intervention: Standardised patients trained in motivational interviewing for smoking cessation (n=47)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Student role-plays (n=46)
Number of subjects: 93
Study: 14677790

Group type: EXPERIMENTAL
Intervention: Topical aspirin paste
Number of subjects: 56

Group type: COMPARATOR
Intervention: Ice pack
Number of subjects: 56
Study: 10971310

Group type: EXPERIMENTAL
Intervention: Policosanol 5 mg day(-1)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Policosanol 10 mg day(-1)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 9214175

Group type: EXPERIMENTAL
Intervention: Brügger technique (lifting with bent legs and stretched back)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Lifting with stretched legs and bent back
Number of subjects: 30
Study: 8408148

Group type: EXPERIMENTAL
Intervention: Open carpal tunnel release
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Endoscopic carpal tunnel release
Number of subjects: 145
Study: 3489270

Group type: EXPERIMENTAL
Intervention: bepridil (2 mg/kg) administered by intravenous infusion over 30 min
Number of subjects: 10

Group type: COMPARATOR
Intervention: placebo (5% glucose solution)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: bepridil (2 mg/kg)
Number of subjects: 10
Study: 31581523

Group type: EXPERIMENTAL
Intervention: Inositol-enhanced arginine silicate oral supplement
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 26279065

Group type: EXPERIMENTAL
Intervention: 1.4 g day-1 omega-3 polyunsaturated fatty acids (PUFAs) plus cognitive-behavioural case management (CBCM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus cognitive-behavioural case management (CBCM)
Number of subjects: 0
Study: 25257941

Group type: EXPERIMENTAL
Intervention: 0.5% 5-fluorouracil with 10% salicylic acid (5-FU/SA)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Cryosurgery
Number of subjects: 66
Study: 23249829

Group type: EXPERIMENTAL
Intervention: Dual therapy (ACE inhibitor ramipril + ARB telmisartan)
Number of subjects: 9628

Group type: COMPARATOR
Intervention: Monotherapy (either ramipril or telmisartan)
Number of subjects: 9628

Group type: EXPERIMENTAL
Intervention: Dual therapy
Number of subjects: 9628

Group type: EXPERIMENTAL
Intervention: Dual therapy vs. monotherapy
Number of subjects: 9628

Group type: COMPARATOR
Intervention: Monotherapy
Number of subjects: 9628
Study: 21697170

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 1800

Group type: COMPARATOR
Intervention: Percutaneous coronary intervention (PCI) with TAXUS Express stents
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 1800

Group type: COMPARATOR
Intervention: PCI
Number of subjects: 1800
Study: 18309160

Group type: EXPERIMENTAL
Intervention: ECP (external counterpulsation)
Number of subjects: 50
Study: 17000359

Group type: EXPERIMENTAL
Intervention: MCE-derived index of myocardial blood flow (A x beta)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: MCE-derived myocardial blood volume fraction (MBVF)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Contrast-enhanced magnetic resonance imaging (CE-MRI)
Number of subjects: 30
Study: 14514768

Group type: EXPERIMENTAL
Intervention: 4.0 microg/kg i.v. glycopyrrolate
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 10966249

Group type: EXPERIMENTAL
Intervention: EPO group (received iv iron and epoetin alfa 300 IU/kg subcutaneously on days 1, 3, 5, 7, and 9)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Iron group (received 20 mg of iron saccharate intravenously daily for 14 days)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (received no additional therapy)
Number of subjects: 36
Study: 8798250

Group type: EXPERIMENTAL
Intervention: Highest quartile for BMI in 10-14 year old girls
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Highest quartile for BMI in 15-19 year olds
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BMI increase with age
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mean fasting insulin levels
Number of subjects: 0
Study: 1451070

Group type: EXPERIMENTAL
Intervention: Concurrent radiation therapy (RT) with vinblastine
Number of subjects: 29

Group type: COMPARATOR
Intervention: Radiation therapy (RT) alone
Number of subjects: 29
Study: 6463915

Group type: EXPERIMENTAL
Intervention: Oxitropium bromide (400-600 micrograms)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31210105

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (50,000 IU every 2 weeks for 12 weeks)
Number of subjects: 55
Study: 29966780

Group type: EXPERIMENTAL
Intervention: WFNS grade I aSAH patients
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Age (per increasing decade)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Delayed cerebral ischemia
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Pneumonia
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Meningitis
Number of subjects: 132
Study: 27185077

Group type: EXPERIMENTAL
Intervention: Biofeedback
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (oral simethicone)
Number of subjects: 24
Study: 25316142

Group type: EXPERIMENTAL
Intervention: Thiamphenicol plus sodium hyaluronate 0.2% plus xylitol 5% (group B)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Thiamphenicol alone (group A)
Number of subjects: 51
Study: 21688350

Group type: EXPERIMENTAL
Intervention: UC HAT
Number of subjects: 47

Group type: COMPARATOR
Intervention: BAC
Number of subjects: 47
Study: 20140409

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (50 units) injected into the plantar fascia
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal saline injected into the plantar fascia
Number of subjects: 50
Study: 18059588

Group type: EXPERIMENTAL
Intervention: Pre
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: ImmPost
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Delay
Number of subjects: 9

Group type: COMPARATOR
Intervention: Pre and Delay
Number of subjects: 9
Study: 15750366

Group type: EXPERIMENTAL
Intervention: Emotional stimuli (positive and negative emotions)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Neutral stimuli
Number of subjects: 52
Study: 11875329

Group type: EXPERIMENTAL
Intervention: Tibolone (n = 56)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Raloxifene (n = 48)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Control group (n = 27)
Number of subjects: 131
Study: 11459198

Group type: EXPERIMENTAL
Intervention: Atovaquone
Number of subjects: 9

Group type: COMPARATOR
Intervention: Trimethoprim/sulfamethoxazole
Number of subjects: 9
Study: 10210990

Group type: EXPERIMENTAL
Intervention: High titre vaccine (10(3.9) and 10(4.0) pfu)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Low titre vaccine (10(2.7) pfu)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Vaccination age of ≤ 14 months
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Household contact with varicella
Number of subjects: 181
Study: 7941193

Group type: EXPERIMENTAL
Intervention: Dynamic MRI with gadolinium‐diethylenetriamine pentaacetic acid (0.1 mmol/kg)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Follow-up controls
Number of subjects: 41
Study: 3328684

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31464087

Group type: EXPERIMENTAL
Intervention: DSP-6952
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88